Developing Artificial Intelligence-based Precision Therapeutics for Patients with Autoimmune and Chronic Inflammatory Diseases

Athos Therapeutics Inc. is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Identification of DrugTargets

Athos Therapeutics Innovative Drug Discovery & Development Platform

Athos has developed a unique platform able to identify and develop novel drugs for patients with autoimmune and chronic inflammatory diseases. This approach is based on the integration of medicinal chemistry and systems biology through machine learning.

  • First, we identify novel factors related to the disease pathobiology based on the integration of human clinical and molecular datasets from patients with autoimmune diseases.
  • Second, we synthesize small molecules based on our computational medicinal chemistry platform.

Taken together these two approaches, combined with a machine learning algorithm, identify the best compounds that safely and efficiently target key disease factors.

1123 West Carson Street
Torrance, CA 90502

building exterior